Table 2 Distribution of CMS & Immunoscore for non-pedunculated T1 CRCs and comparison between T1 CRCs with and without poor differentiation, lymphovascular invasion, deep submucosal invasion and tumor budding (assessed in the subgroup, n = 223 patients).

From: Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study

 

CMSa

 

Immunoscoreb

 

Classification for CMS or Immunoscore, n (%)

CMS1 (MSI)

n = 16 (7.2)

CMS2/3

n = 203 (91)

CMS4

n = 4 (1.8)

p

I-low

n = 53 (25)

I-high

n = 159 (75)

p

Location in colorectum

   

<0.0001*

  

0.48

 Right-sided colon

13 (20.0)

50 (76.9)

2 (3.1)

 

12 (19.4)

50 (80.6)

 

 Left-sided colon

3 (2.5)

117 (96.7)

1 (0.8)

 

31 (27.4)

82 (72.6)

 

 Rectum

0 (0)

36 (97.3)

1 (2.7)

 

10 (27.0)

27 (73.0)

 

CMS vs. Immunoscore

   

  

0.14

 CMS1, n = 15

 

1 (6.7)

14 (93.3)

 

 CMS 2/3, n = 193

 

52 (26.9)

141 (73.1)

 

 CMS 4, n = 4

 

0 (0)

4 (100)

 

Differentiation grade

   

0.19

  

0.27

 Moderate/good, n = 167

15 (9.0)

149 (89.2)

3 (1.8)

 

37 (23.1)

123 (76.9)

 

 Poor, n = 54

1 (1.9)

52 (96.3)

1 (1.9)

 

16 (31.4)

35 (68.6)

 

Lymphovascular invasion

   

0.15

  

0.87

 Absent, n = 133

13 (9.8)

117 (88.0)

3 (2.3)

 

31 (24.4)

96 (75.6)

 

 Present, n = 87

3 (3.4)

83 (95.4)

1 (1.2)

 

21 (25.6)

61 (74.4)

 

Submucosal invasion depth

   

0.62

  

1.0

 Superficial, n = 23

1 (4.3)

21 (91.3)

1 (4.3)

 

5 (22.7)

17 (77.3)

 

 Deep, n = 176

13 (7.4)

160 (90.9)

3 (1.7)

 

39 (23.4)

128 (76.6)

 

Tumor budding

   

0.82

  

0.02

 Low-grade, n = 156

13 (8.3)

140 (89.7)

3 (1.9)

 

30 (20.1)

119 (79.9)

 

 High-grade, n = 57

3 (5.3)

53 (93.0)

1 (1.8)

 

20 (37.7)

33 (62.3)

 
  1. Differentiation grade could not be determined in 2 patients, lymphovascular invasion in 3 patients, invasion depth in 24 patients, and tumor budding in 10 patients.
  2. CMS  Consensus Molecular Subtype, MSI microsatellite instable, I-low Immunoscore Low, I-high Immunoscore High.
  3. *p value for CMS1 or CMS2/3/4 and left-sided (including rectum) vs. right-sided colon.
  4. aCMS1 subtype was based on MSI-status; CMS2/3 or 4 based on immunohistochemical CMS-classifier.
  5. bInsufficient cores were assessable for CD3/CD8 densities for total Immunoscore (n = 11).